Lacktman, Ferrante Featured in mHealthIntelligence about Telestroke Services
14 February 2018
mHealthIntelligence
Partner Nate Lacktman and Senior Counsel Thomas Ferrante were quoted in an mHealthIntelligence article, “FDA OKs mHealth App That Uses AI to Spot Strokes, Alert Specialists,” about what the Bipartisan Budget Act of 2018’s elimination of originating-site restrictions for telestroke services will mean for health care systems and institutions with established stroke programs.
The FDA recently approved an mHealth application, Viz.AI, which uses artificial intelligence software to analyze CT scans for signs of a stroke, then sends a message to a neurologist. It contains specially-designed mobile units that can start treatment when transmitted to the patient’s location, and telestroke platforms that allow health care providers to reach neurologists who are based anywhere.
In conjunction with this news, mHealthIntelligence featured Lacktman and Ferrante’s comments from the telestroke section of their recent Health Care Law Today blog post, which analyzes the new federal funding bill: “Allowing more qualified originating sites, such as the patient’s home, ambulances and mobile stroke units, will provide broader options for health care systems that do not have constant access to a neurologist and allow institutions with established stroke programs opportunities for destination medicine and new patients.”
The FDA recently approved an mHealth application, Viz.AI, which uses artificial intelligence software to analyze CT scans for signs of a stroke, then sends a message to a neurologist. It contains specially-designed mobile units that can start treatment when transmitted to the patient’s location, and telestroke platforms that allow health care providers to reach neurologists who are based anywhere.
In conjunction with this news, mHealthIntelligence featured Lacktman and Ferrante’s comments from the telestroke section of their recent Health Care Law Today blog post, which analyzes the new federal funding bill: “Allowing more qualified originating sites, such as the patient’s home, ambulances and mobile stroke units, will provide broader options for health care systems that do not have constant access to a neurologist and allow institutions with established stroke programs opportunities for destination medicine and new patients.”
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."